ES2038766T3 - 4-aril-5-carbamoil-1,4-dihidropiridinas. - Google Patents

4-aril-5-carbamoil-1,4-dihidropiridinas.

Info

Publication number
ES2038766T3
ES2038766T3 ES198888309039T ES88309039T ES2038766T3 ES 2038766 T3 ES2038766 T3 ES 2038766T3 ES 198888309039 T ES198888309039 T ES 198888309039T ES 88309039 T ES88309039 T ES 88309039T ES 2038766 T3 ES2038766 T3 ES 2038766T3
Authority
ES
Spain
Prior art keywords
alcoxi
alkyl
fenile
piperacinyl
substitutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888309039T
Other languages
English (en)
Inventor
Kelvin Dr. Cooper
Kenneth Dr. Richardson
Michael Jonathan Dr. Fray
John Dr. Steele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878722977A external-priority patent/GB8722977D0/en
Priority claimed from GB888804441A external-priority patent/GB8804441D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Application granted granted Critical
Publication of ES2038766T3 publication Critical patent/ES2038766T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)

Abstract

ANTAGONISTAS DEL FACTOR DE ACTIVACION PLAQUETARIA DE FORMULA(I), EN DONDE R ES FENIL O FENIL SUSTITUIDO POR UNO O MAS SUSTITUYENTES ELEGIDOS ENTRE NITRO HALO, C1 A C4 ALQUILO, C1 A C4 ALCOXI, ARILO (C1 - C4)ALCOXI, FLUORO, (C1 - C4)ALCOXI, C1 - C4 ALCOXI, C1 - C4 ALQUILTIO, C1 - C4 ALQUILSULFONILO, HIDROXILO, TRIFLUOROMETILO Y CIANO, O ES FENILO FUSIONADO A UN ANILLO DIOXOLO; R1 Y R2 SON CADA UNO INDEPENDIENTEMENTE H O C1 - C6 ALQUILO, O R1 Y R2 JUNTOS COMPLETAN UN PIRROLIDINILO PIPERIDINO, MORFOLINO, PIPERACINILO, N - (C1 - C4 ALQUIL) PIPERACINILO O N C2 - C4 ALCANOIL - PIPERACINILO GRUPO; TAMBIEN SE DESCUBREN LOS SUSTITUYENTES DE R2, Z, Y, X; Y SUS SALES ACEPTABLES FARMACOLOGICAMENTE.
ES198888309039T 1987-09-30 1988-09-29 4-aril-5-carbamoil-1,4-dihidropiridinas. Expired - Lifetime ES2038766T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878722977A GB8722977D0 (en) 1987-09-30 1987-09-30 Therapeutic agents
GB888804441A GB8804441D0 (en) 1988-02-25 1988-02-25 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2038766T3 true ES2038766T3 (es) 1993-08-01

Family

ID=26292797

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888309039T Expired - Lifetime ES2038766T3 (es) 1987-09-30 1988-09-29 4-aril-5-carbamoil-1,4-dihidropiridinas.

Country Status (26)

Country Link
US (3) US4935430A (es)
EP (1) EP0310386B1 (es)
JP (2) JP2660016B2 (es)
KR (1) KR900008318B1 (es)
CN (1) CN1032648C (es)
AU (2) AU597190B2 (es)
CA (1) CA1340785C (es)
CY (1) CY1722A (es)
DE (1) DE3866077D1 (es)
DK (1) DK170376B1 (es)
EG (1) EG18563A (es)
ES (1) ES2038766T3 (es)
FI (1) FI93444C (es)
GR (1) GR3003468T3 (es)
HK (1) HK66093A (es)
HU (1) HU201061B (es)
IE (1) IE61045B1 (es)
IL (1) IL101332A0 (es)
MY (1) MY104933A (es)
NO (1) NO168107C (es)
NZ (1) NZ226397A (es)
PH (1) PH26046A (es)
PL (1) PL157186B1 (es)
PT (1) PT88614B (es)
SG (1) SG49393G (es)
YU (1) YU46698B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906324D0 (en) * 1989-03-20 1989-05-04 Pfizer Ltd 1,4-dihydropyridines
US4990518A (en) * 1989-09-13 1991-02-05 G. D. Searle & Co. Pharmacologically active heteroaryl substituted imidazo (4,5-c) pyridines
GB9010404D0 (en) * 1990-05-09 1990-06-27 Pfizer Ltd Therapeutic agents
GB9015524D0 (en) * 1990-07-13 1990-08-29 Pfizer Ltd Therapeutic agents
GB9019409D0 (en) * 1990-09-05 1990-10-17 Pfizer Ltd Therapeutic agents
DK1130017T3 (da) 1990-11-30 2005-10-10 Otsuka Pharma Co Ltd Azolderivater og deres anvendelse som superoxidradikalinhibitorer
US5288866A (en) * 1991-12-20 1994-02-22 American Cyanamid Company 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
WO1999062908A2 (en) * 1998-06-04 1999-12-09 Abbott Laboratories Cell adhesion-inhibiting antinflammatory compounds
WO2000075145A1 (en) * 1999-06-03 2000-12-14 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
EP1311269B1 (en) * 2000-08-04 2012-02-29 DMI Biosciences, Inc. Method of using diketopiperazines and composition containing them
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
CN113999167B (zh) * 2021-10-18 2023-09-29 蚌埠中实化学技术有限公司 一种4-氯-2,6-二甲基-3-硝基吡啶的制备方法
CN117568743B (zh) * 2024-01-15 2024-03-19 江苏普坦科金属科技有限公司 一种铁基材料的表面耐腐蚀耐磨处理工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971791A (en) * 1972-03-06 1976-07-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
US4317909A (en) * 1980-03-24 1982-03-02 Sterling Drug Inc. Preparation of 1,3-dihydro-5-(pyridinyl)-2H-imidazo[4,5-b]pyridin-2-ones
US4353905A (en) 1981-09-17 1982-10-12 Warner-Lambert Company Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3363743D1 (en) 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
GB8620880D0 (en) * 1986-08-29 1986-10-08 Pfizer Ltd Therapeutic agents
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
NO874194L (no) * 1986-11-07 1988-05-09 Pfizer Ltd Fremgangsmaate ved fremstilling av dihydro-pyridinderivater
US4820842A (en) * 1986-11-19 1989-04-11 Warner-Lambert Company 2-substituted-1,4-dihydropyridines
GB8712747D0 (en) * 1987-05-30 1987-07-01 Pfizer Ltd Therapeutic agents
GB8803963D0 (en) * 1988-02-19 1988-03-23 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
CN1032439A (zh) 1989-04-19
NO168107C (no) 1992-01-15
PH26046A (en) 1992-01-29
HUT48872A (en) 1989-07-28
EG18563A (en) 1993-08-30
HU201061B (en) 1990-09-28
NO884333D0 (no) 1988-09-29
NZ226397A (en) 1990-11-27
PT88614A (pt) 1989-07-31
FI93444B (fi) 1994-12-30
US4935430A (en) 1990-06-19
IL101332A0 (en) 1992-11-15
JPH01113367A (ja) 1989-05-02
FI884471A0 (fi) 1988-09-29
GR3003468T3 (en) 1993-02-17
AU2297388A (en) 1989-04-06
YU46698B (sh) 1994-04-05
IE61045B1 (en) 1994-09-07
DK544588D0 (da) 1988-09-29
PL157186B1 (pl) 1992-05-29
CA1340785C (en) 1999-10-12
PL274977A1 (en) 1989-08-21
JP2898256B2 (ja) 1999-05-31
AU597190B2 (en) 1990-05-24
AU617256B2 (en) 1991-11-21
KR900008318B1 (ko) 1990-11-12
YU182088A (en) 1990-06-30
DK544588A (da) 1989-05-11
AU6126190A (en) 1990-11-29
NO168107B (no) 1991-10-07
IE882944L (en) 1989-03-30
CY1722A (en) 1994-05-06
HK66093A (en) 1993-07-16
US5063237A (en) 1991-11-05
DE3866077D1 (de) 1991-12-12
PT88614B (pt) 1993-07-30
JP2660016B2 (ja) 1997-10-08
FI884471A (fi) 1989-03-31
SG49393G (en) 1993-07-09
EP0310386B1 (en) 1991-11-06
MY104933A (en) 1994-07-30
JPH09315973A (ja) 1997-12-09
US5120747A (en) 1992-06-09
EP0310386A2 (en) 1989-04-05
DK170376B1 (da) 1995-08-14
KR890005054A (ko) 1989-05-11
EP0310386A3 (en) 1989-11-15
FI93444C (fi) 1995-04-10
CN1032648C (zh) 1996-08-28
NO884333L (no) 1989-03-31

Similar Documents

Publication Publication Date Title
ES2038766T3 (es) 4-aril-5-carbamoil-1,4-dihidropiridinas.
ES2052675T3 (es) 3-(4-piperazinil-sustituido en 1)butil)-4-tiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
NO905306D0 (no) Spirocykliske forbindelser som inneholder nitrogen.
ES2161231T3 (es) Compuestos heterociclicos como antagonistas de bradiquinina.
AR051202A1 (es) Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
ES2033049T3 (es) Procedimiento para preparar derivados de oxa- o tia-zolina.
ES2153841T3 (es) Antagonistas de la taciquinina.
RO82508B (ro) PROCEDEU PENTRU PREPARAREA UNOR DERIVATI DE 3-(1-PIPERIDINILACHIL)-4H-PIRIDO-(1,2-a)- PIRIMIDIN-4-ONA
GT199900119A (es) Jarabe antihistaminico estabilizado.
DE69811070D1 (de) 9-azabicyclo(3.3.1)non-2-ene und nonanderivate als liganden der nicotinergen rezeptoren
ES2031841T3 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona.
ATE31307T1 (de) Benzofuran- und benzopyrancarboxamid-derivate.
HN1998000034A (es) Quinoxalinadionas
ES2063153T3 (es) Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos.
AR247389A1 (es) Derivados de 2,4-diamino-5-ciano-pirimidinas, excluidos sus usos terapeuticos, procedimiento para su preparacion, intermediarios y composiciones que las contienen como antiparasitarios
CO4340623A1 (es) Derivados de indolina, metodo de preparacion y uso
ES2009785B3 (es) Procedimiento para preparar derivados de tioxantona.
CO4410319A1 (es) Derivados de fenetanolamina
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES2045044T3 (es) Derivados de sulfonamidolfenilo y agentes terapeuticos y preventivos de la arritmia que contienen los mismos.
AR242208A1 (es) Procedimiento para la produccion de tetrahidro-2-heterocicloalquil-pirido¡4,3-b¿-indoles.
ES2056146T3 (es) Monopersulfatos de acidos amino-(poli)percarboxilicos.
AR013152A1 (es) Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n.
DK448684A (da) Alkyldiaminderivater og deres anvendelse som laegemidler
ES552044A0 (es) Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310386

Country of ref document: ES